User profiles for "author:Ania Syrowatka"

Ania Syrowatka

Postdoctoral Fellow, Brigham and Women's Hospital & Harvard Medical School
Verified email at bwh.harvard.edu
Cited by 1004

[HTML][HTML] Predictors of distress in female breast cancer survivors: a systematic review

A Syrowatka, A Motulsky, S Kurteva, JA Hanley… - Breast cancer research …, 2017 - Springer
Purpose Unmanaged distress has been shown to adversely affect survival and quality of life
in breast cancer survivors. Fortunately, distress can be managed and even prevented with …

[HTML][HTML] The potential of artificial intelligence to improve patient safety: a scoping review

DW Bates, D Levine, A Syrowatka, M Kuznetsova… - NPJ digital …, 2021 - nature.com
Artificial intelligence (AI) represents a valuable tool that could be used to improve the safety
of care. Major adverse events in healthcare include: healthcare-associated infections …

[HTML][HTML] Leveraging artificial intelligence for pandemic preparedness and response: a scoping review to identify key use cases

A Syrowatka, M Kuznetsova, A Alsubai… - NPJ digital …, 2021 - nature.com
Artificial intelligence (AI) represents a valuable tool that could be widely used to inform
clinical and public health decision-making to effectively manage the impacts of a pandemic …

[HTML][HTML] The safety of inpatient health care

DW Bates, DM Levine, H Salmasian… - … England Journal of …, 2023 - Mass Medical Soc
Background Adverse events during hospitalization are a major cause of patient harm, as
documented in the 1991 Harvard Medical Practice Study. Patient safety has changed …

[HTML][HTML] Features of computer-based decision aids: systematic review, thematic synthesis, and meta-analyses

A Syrowatka, D Krömker, AN Meguerditchian… - Journal of medical …, 2016 - jmir.org
Background Patient information and education, such as decision aids, are gradually moving
toward online, computer-based environments. Considerable research has been conducted …

[HTML][HTML] Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

A Syrowatka, W Song, MG Amato, D Foer… - The Lancet Digital …, 2022 - thelancet.com
Adverse drug events (ADEs) represent one of the most prevalent types of health-care-
related harm, and there is substantial room for improvement in the way that they are …

Informed consent documents do not encourage good-quality decision making

JC Brehaut, K Carroll, G Elwyn, R Saginur… - Journal of clinical …, 2012 - Elsevier
OBJECTIVE: Informed consent for research has emphasized information provision over
support to people making a difficult decision. We assessed the extent to which existing …

[HTML][HTML] Intelligent telehealth in pharmacovigilance: a future perspective

H Edrees, W Song, A Syrowatka, A Simona, MG Amato… - Drug Safety, 2022 - Springer
Pharmacovigilance improves patient safety by detecting and preventing adverse drug
events. However, challenges exist that limit adverse drug event detection, resulting in many …

[PDF][PDF] Evaluating patient, family and public engagement in health services improvement and system redesign

J Abelson, A Humphrey, A Syrowatka, J Bidonde… - Healthc Q, 2018 - academia.edu
Evaluating Patient, Family and Public Engagement in Health Services Improvement and
System Redesign Page 1 Healthcare Quarterly Vol.21 Special Issue 2018 61 Abstract As …

[HTML][HTML] Achieving the “triple aim” for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence …

BK Potter, P Chakraborty, JB Kronick, K Wilson… - Genetics in …, 2013 - Elsevier
Across all areas of health care, decision makers are in pursuit of what Berwick and
colleagues have called the “triple aim”: improving patient experiences with care, improving …